Principal Financial Group
PGNX

Principal Financial Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-666,732
Closed -$2.53M 2405
2020
Q1
$2.53M Sell
666,732
-28,123
-4% -$107K ﹤0.01% 1531
2019
Q4
$3.54M Sell
694,855
-12,773
-2% -$65K ﹤0.01% 1617
2019
Q3
$3.58M Buy
707,628
+4,436
+0.6% +$22.4K ﹤0.01% 1605
2019
Q2
$4.34M Buy
703,192
+164
+0% +$1.01K ﹤0.01% 1575
2019
Q1
$3.26M Sell
703,028
-6,693
-0.9% -$31.1K ﹤0.01% 1657
2018
Q4
$2.98M Buy
709,721
+8,257
+1% +$34.7K ﹤0.01% 1645
2018
Q3
$4.4M Buy
701,464
+105,765
+18% +$663K ﹤0.01% 1639
2018
Q2
$4.79M Buy
595,699
+44,462
+8% +$357K ﹤0.01% 1608
2018
Q1
$4.11M Buy
551,237
+2,945
+0.5% +$22K ﹤0.01% 1615
2017
Q4
$3.26M Sell
548,292
-40,462
-7% -$241K ﹤0.01% 1678
2017
Q3
$4.33M Sell
588,754
-6,095
-1% -$44.9K ﹤0.01% 1597
2017
Q2
$4.04M Buy
594,849
+47,647
+9% +$324K ﹤0.01% 1616
2017
Q1
$5.17M Buy
547,202
+534,759
+4,298% +$5.05M 0.01% 1521
2016
Q4
$108K Buy
12,443
+417
+3% +$3.62K ﹤0.01% 2149
2016
Q3
$76K Hold
12,026
﹤0.01% 2123
2016
Q2
$51K Hold
12,026
﹤0.01% 2135
2016
Q1
$52K Buy
12,026
+243
+2% +$1.05K ﹤0.01% 2124
2015
Q4
$72K Hold
11,783
﹤0.01% 2128
2015
Q3
$67K Sell
11,783
-7,357
-38% -$41.8K ﹤0.01% 2119
2015
Q2
$143K Sell
19,140
-487
-2% -$3.64K ﹤0.01% 2095
2015
Q1
$118K Buy
19,627
+1,502
+8% +$9.03K ﹤0.01% 2087
2014
Q4
$137K Buy
+18,125
New +$137K ﹤0.01% 2085
2014
Q2
Sell
-29,154
Closed -$119K 2338
2014
Q1
$119K Buy
+29,154
New +$119K ﹤0.01% 2215
2013
Q4
Sell
-23,268
Closed -$117K 2324
2013
Q3
$117K Buy
+23,268
New +$117K ﹤0.01% 2209